The present study deals with the elaborated overview of comparative study of in-process and finished product quality control tests for Parenteral products taking compendia specifications of Indian Pharmacopoeia (IP), British Pharmacopoeia (BP), United States Pharmacopoeia (USP), European Pharmacopoeia (EP) and Japanese Pharmacopoeia (JP) into consideration. Injectables occupy a considerable prominence in world market irrespective of diminishing growth in the pharmaceutical market for 2-3 years. The advancements in technology up-gradation and investments have provided immense growth opportunities for Injectable to emerge in the world's pharmaceutical industry in recent years. According to research report, "UK Injectable Market Outlook to 2017", the market is anticipated to grow at a rate of approximately 4.5% during 2012-2017. The increasing need of injectables for diseases like diabetes, infectious diseases and arthritis is primarily driving the market. A lot of investment is being done in research and development of Injectable in order to improve their medical outcomes. Here it is worth mentioning that many countries governments have significantly contributed towards the development of innovative medicines. Certain pharmaceutical firms in world injectable market have established their foothold given the diverse and innovative product offerings. Several small pharma majors too have been aggressively competing with big pharmaceutical players in order to establish themselves in the market. This review highlights the basic types of injectable preparations and their quality control tests with their standards.
Introduction
Injectable Preparations are also called as Parenteral preparations. Injectable preparations are sterile preparations and are administered by injection, infusion or implantation. An injection is an infusion method of putting fluid into the body, usually with a syringe and a hollow needle which is pierced through the skin to a sufficient depth for the material to be administered into the body.
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An injection follows a Parenteral route of administration; that is, administration via a route other than through the digestive tract. There are several methods of injection or infusion used in humans, including intradermal, subcutaneous, intramuscular, intravenous, intraosseous, intraperitoneal, intrathecal, epidural, intracardiac, intraarticular, intracavernous, and intravitreal. Rodents used for research are often administered intra cerebral and intra cerebro ventricular injections as well. Long-acting forms of subcutaneous / intramuscular injections are available for various drugs, and are called depot injections. Injections are among the most common health care procedures, with at least 16 billion administered in developing and transitional countries each year. 95% of injections are administered in curative care, 3% are for immunization, and the rest for other purposes, such as blood transfusions. Approximately 40% of injections worldwide are administered with unsterilized, reused syringes and needles, and in some countries this proportion is 70%, exposing millions of people to infections 1, 2 . 
Characterization of Injectables

Powder for injection or Infusion
Powder for injections are sterile solid substances (including freeze dried material) which are distributed in their final containers which, when shaken with the prescribed volume of the appropriate sterile liquid, rapidly form clear and practically particle-free solutions or uniform suspension. Powders for injection (PIs) are a popular parenteral dosage form for drugs that cannot be marketed as ready-to-use injectables because of their instability in an aqueous environment. PIs are relatively simple with respect to formulation and process development. However, their performance and stability.
Intravenous Infusion
These are sterile aqueous solutions or emulsions with water as continuous phase. When a drug is infused intravenously at a constant rate, a plateau concentration will be reached progressively in the most frequently most of the cases follows first order kinetics. On starting the infusion, there is no drug in the body and therefore, no elimination. The amount of drug in the body then rises, but as the drug concentration increases, so does the rate of elimination. Thus, the rate of elimination will keep rising until it matches the rate of infusion. The amount of drug in the body is then constant and is said to have reached a steady state or plateau.
Extractable volume
Suspensions should be shaken before the contents are withdrawn. Oily injections may be warmed but should be cooled to 250 C before carrying out the test. Table 1 . No of containers to be used for the test as per to BP, USP, EP and JP.
a) Single dose containers b) Multi dose containers
Volume of the solution
No of containers to be used for the test ≥ 10 ml 1 3-10 ml 3 < 3 ml 5
Concentrated solutions for injections
Concentrated solutions for injections are sterile solutions that are intended for administration by injection or by IV infusion only after dilution with suitable dilution with a suitable liquid. After dilutions these preparations should comply with the requirements of tests for injection or intravenous infusions as appropriate.
Implants
Implants are sterile solid preparations of size and shape for implantation into body tissues so as to release active ingredient over an extended period of time. An implant is a medical device manufactured to replace a missing biological structure, support a damaged biological structure, or enhance an existing biological structure. Medical implants are man-made devices, in contrast to a transplant, which is a transplanted biomedical tissue. The surface of implants that contact the body might be made of a biomedical material such as titanium, silicone or apatite depending on what is the most functional. In some cases implants contain electronics e.g. artificial pacemaker and cochlear implants. Some implants are bioactive, such as subcutaneous drug delivery devices in the form of implantable pills or drug-eluting stents.
Quality Control Testing of Injectable Preparations 1,2,3,4,5,6,7
The quality of Injectable is the sum of all parameters that contribute to safety and therapeutic efficacy of the drug. The USP compendial requirements has recommended the following tests for Injectable products. 
Method II: Where the nominal volume is more than 5ml
Transfer the contents of not less than 3 containers separately to dry graduated cylinders such that the volume to be measured occupies not less than 40% of the nominal volume of the cylinder and measure the volume transferred. The contents of each container are not less than the nominal volume and not more than 110% of the nominal volume.
Particulate matter in injections
The preparations intended for parenteral use should be free from particulate matter and should be clear when inspected visually. Two methods are described by USP according to the filled volume of the product to be tested. For large volume parenterals (LVP's), a filtration followed by microscopical examination procedure is used. For small volume parenterals (SVP's) a light obscuration based sensor containing electronic liquidborne particle counter system is used. The USP standards are met if the LVP's under test contain NMT 50 particles per ml of 10μ m, and NMT 5 particles per ml of 25μm in an effective linear dimensional fashion. The USP standards are met if the SVP's under test contain NMT 10,000 particles per container of 10 μm, and NMT 1000 particles per container of 25μm in an effective spherical diameter. 
5) Pyrogen test
It is performed by using rabbits as test animals. Initially 10 ml/kg body weight of an animal is injected through rat vein at 37±2ºC within ten minutes from start of administration. The temperatures are recorded at 1, 2 and 3 hours after injection.
6) Sterility test
Growth promotion medium and incubation conditions are selected based on the test microorganism. The sterility test is done using direct transfer and membrane filtration techniques. Membrane filtration technique is suitable for liquids, soluble powders with bacteriostatic or fungi static properties, oils, creams and ointments. Sterility test by direct transfer is performed by aseptic transfer of specified volume from test container to culture medium and incubated for 14 days and visual observation of medium is done on 3rd, 4th, 5th, 7th, 8th and 14th day. A membrane filter with porosity of 0.45μm with diameter of 47mm with flow rate of 55-75 ml of water per minute at a pressure of 70 cm of mercury should be used. The test meets the requirements when no growth is observed and if growth is observed then the test is repeated in the second stage and generally second stage is repeated with double the number of specimens tested in first stage when the test was found to be conducted under faulty or inadequate aseptic techniques.
7) Clarity of Solution
Clarity is performed to ensure that parenteral product is free from foreign particles Constitute the injection as directed on the label. a) The solid dissolves completely, leaving no visible residue as undissolved matter.
b) The constituted injection is not significantly less clear than an equal volume of diluents for water for injections contained in a similar container and examined in the same manner. 
8) Leak Test
